Induction of donor-specific tolerance using superagonistic CD28 antibody in rat renal allografts: Regulatory T-cell expansion before engraftment may be important

Transplantation

Volumn 90, Issue 12, 2010, Pages 1328-1335

  Azuma, Haruhito ^a   Isaka, Yoshitaka ^b   Nomi, Hayahito ^a   Inamoto, Teruo ^a   Li, Xiao Kang ^c   Hounig, Tomas ^d   Takabatake, Yoshitsugu ^b   Ichimaru, Naotsugu ^b   Ibuki, Naokazu ^a   Matsumoto, Kunio ^e   Ubai, Takanobu ^a   Katsuoka, Yoji ^a   Takahara, Shiro ^f  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e KANAZAWA UNIVERSITY   (Japan)

^f OSAKA UNIVERSITY   (Japan)

Author keywords

Adoptive transfer; CD28SA; Donor specific tolerance; HGF; Regulatory T cells

Indexed keywords

IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY CD28; SCATTER FACTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; BROWN NORWAY RAT; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELL INFILTRATION; CONTROLLED STUDY; ENGRAFTMENT; GRAFT PRESERVATION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; IMMUNOLOGICAL TOLERANCE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; WISTAR RAT;

ANIMALS; ANTIGENS, CD28; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; ISOANTIBODIES; KIDNEY TRANSPLANTATION; KYNURENINE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; RATS; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650845696     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182007b59     Document Type: Article

References (27)

1. Tacke M, Hanke G, Hanke T, et al. CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28. Eur J Immunol 1997; 27: 239.
2. Beyersdorf N, Gaupp S, Balbach K, et al. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med 2005; 202: 445.
3. Luhder F, Huang Y, Dennehy KM, et al. Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists. J Exp Med 2003; 197: 955.
4. Azuma H, Isaka Y, Li X, et al. Superagonistic CD28 antibody induces donor-specific tolerance in rat renal allografts.AmJ Transplant 2008; 8: 2004.
5. Evans EJ, Esnouf RM, Manso-Sancho R, et al. Crystal structure of a soluble CD28-Fab complex. Nat Immunol 2005; 6: 271.
6. Margulies DH. CD28, costimulator or agonist receptor? J Exp Med 2003; 197: 949.
7. Kitazawa Y, Fujino M, Li XK, et al. Superagonist CD28 antibody preferentially expanded Foxp3-expressing nTreg cells and prevented graftversus- host diseases. Cell Transplant 2009; 18: 627.
8. Kitazawa Y, Fujino M, Sakai T, et al. Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejection. J Heart Lung Transplant 2008; 27: 362.
9. Azuma H, Tomita N, Kaneda Y, et al. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 2003; 10: 415.
10. Lin H, Bolling SF, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801.
11. Klein L, Khazaie K, von Boehmer H. In vivo dynamics of antigenspecific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 2003; 100: 8886.
12. Walker LS, Chodos A, Eggena M, et al. Antigen-dependent proliferation of CD4- CD25- regulatory T cells in vivo. J Exp Med 2003; 198: 249.
13. Takahashi T, Kuniyasu Y, Toda M, et al. Immunologic self-tolerance maintained by CD25-CD4- naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10: 1969.
14. Chai JG, Tsang JY, Lechler R, et al. CD4-CD25- T cells as immunoregulatory T cells in vitro. Eur J Immunol 2002; 32: 2365.
15. Thornton AM, Shevach EM. CD4-CD25- immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287.
16. Hori S, Haury M, Coutinho A, et al. Specificity requirements for selection and effector functions of CD25-4- regulatory T cells in antimyelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 2002; 99: 8213.
17. Chai JG, Xue SA, Coe D, et al. Regulatory T cells, derived from naive CD4-CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 2005; 79: 1310.
18. Suntharalingam G, Perry MR, Ward S, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006; 355: 1018.
19. Laskowski IA, Pratschke J, Wilhelm MJ, et al. Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J Am Soc Nephrol 2002; 13: 519.
20. Dong VM, Yuan X, Coito AJ, et al. Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection. Transplantation 2002; 73: 1310.
21. Benkhoucha M, Santiago-Raber ML, Schneiter G, et al. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25-Foxp3- regulatory T cells. Proc Natl Acad Sci USA 2010; 107: 6424.
22. Rutella S, Bonanno G, Procoli A, et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10-IL- 12low/neg accessory cells with dendritic-cell features. Blood 2006; 108: 218.
23. Azuma H, Takahara S, Matsumoto K, et al. Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 2001; 12: 1280.
24. Yamaura K, Ito K, Tsukioka K, et al. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: Induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation 2004; 110: 1650.
25. Lin CH, Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol 2003; 33: 626.
26. Beyersdorf N, Hanke T, Kerkau T, et al. Superagonistic anti-CD28 antibodies: Potent activators of regulatory T cells for the therapy of autoimmune diseases. Ann Rheum Dis 2005; 64(suppl 4): iv91.
27. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440.